At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 137 enrolled

Drug / intervention

fix dose r-FSH (Gonal-f) +2 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02108223

NCT02108223Phase 4Completed

Compare CT.gov

In This Study, the Addition of rLH, Increasing the Dose of rFSH and the Control Groups Regarding the Results of IVF in These Patients.

Sisli Hamidiye Etfal Training and Research Hospital·interventional·Posted Apr 9, 2014·Updated Mar 20, 2015

In Brief

A Phase 4 clinical trial evaluating fix dose r-FSH (Gonal-f), r-LH supplementation, and 1 other intervention for Infertility. Completed, enrolled 137 participants.

Detailed Summary

The investigators aimed to evaluate patients who had In-vitro fertilization treatment and who had COH (controlled ovarian hyperstimulation) cycles applying long protocol with GnRH (gonadotropin-releasing hormone) analogue with suboptimal response to the rFSH. The investigators evaluated and compared the addition of rLH, increasing the dose of rFSH and the control groups regarding the results of IVF in these patients.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsInfertility

Countries--

CollaboratorsSelcuk University

Timeline

Phase 4CompletedFinished

200920102011201220132014201520162017201820192020202120222023202420252026

Enrollment StartJan 2009

Primary CompletionApr 2011

First PostedApr 2014

TodayJul 2026

First PostedApr 9, 2014

Enrollment StartJan 1, 2009

Primary CompletionApr 1, 2011

TodayJul 2, 2026

Enrollment to primary: 2.3 yearsPosted 12.2 years ago

Interventions

fix dose r-FSH (Gonal-f)drug

recombinant follicle stimulation

r-LH supplementationdrug

recombinant luteinizing hormone

r-FSH (Gonal-f)drug

recombinant follicle stimulation hormone